Ameriprise
IRON icon

Ameriprise’s Disc Medicine IRON Stock Holding History

Ameriprise’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.36M Buy
45,874
+37
+0.1% +$2.54K ﹤0.01% 2809
2026
Q1 		$2.93M Sell
45,837
-37,147
-45% -$2.58M ﹤0.01% 2767
2025
Q4 		$6.59M Buy
82,984
+8,634
+12% +$730K ﹤0.01% 2236
2025
Q3 		$4.91M Sell
74,350
-47,170
-39% -$2.81M ﹤0.01% 2470
2025
Q2 		$6.44M Buy
121,520
+53,615
+79% +$2.52M ﹤0.01% 2154
2025
Q1 		$3.37M Buy
67,905
+62,627
+1,187% +$3.48M ﹤0.01% 2594
2024
Q4 		$335K Buy
+5,278
New +$305K ﹤0.01% 3684

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Ameriprise's IRON Position: Q2 2026 in Review

Ameriprise increased its Disc Medicine (IRON) stake by 0.08% in Q2 2026, buying an estimated $2.54K and bringing the position to 45,874 shares worth $3.36M. The position accounts for ﹤0.01% of the portfolio, ranked #2809.

Ameriprise first reported a position in IRON in Q4 2024 and has held it in 7 quarters since. The position peaked at $6.59M in Q4 2025. 216 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • Ameriprise held 45,874 shares of Disc Medicine worth $3.36M as of Q2 2026.
  • Ameriprise bought 37 Disc Medicine shares in Q2 2026, an estimated $2.54K.
  • Disc Medicine made up ﹤0.01% of Ameriprise's portfolio in Q2 2026, its #2809 holding.
  • Ameriprise first reported a position in Disc Medicine in Q4 2024 and has held it in 7 quarters since.
  • Ameriprise's Disc Medicine position peaked at $6.59M in Q4 2025.
  • 216 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on Ameriprise's 13F filing for Q2 2026, filed 14 Aug 2026.